Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Voliphage-M 0.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Franco-Indian Pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Voliphage-M 0.3 Tablet SR

Diabetease-MX 0.3mg Extended-Release tablets are antidiabetic medications combining multiple agents to manage type 2 diabetes in adults. These tablets help regulate blood glucose. Administer Diabetease-MX 0.3mg ER tablets with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Potential side effects, such as nausea, altered taste perception, appetite changes, flatulence, abdominal discomfort, diarrhea, and skin rashes, are generally transient. Persistent or concerning side effects necessitate medical consultation. Your physician can address or manage bothersome side effects. Diabetease-MX 0.3mg ER tablets are contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their doctor before commencing treatment. Pregnant or lactating women must consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Voliphage-M 0.3 Tablet SR

Managing Type 2 diabetes

Major Benefits of Voliphage-M 0.3 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. It's recommended to take Voliphage-M 0.3 mg Extended-Release tablet with a meal.

Common Side effects of Voliphage-M 0.3 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voliphage-M 0.3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Voliphage-M 0.3mg Extended-Release tablet with a meal.

How Voliphage-M 0.3 Tablet SR works:

Extended-release Voliphage-M 0.3mg tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voliphage-M 0.3 Tablet SR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voliphage-M 0.3 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Voliphage-M 0.3 Tablet SR while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Extended-release Voliphage-M 0.3mg tablets generally do not impair driving ability. Nevertheless, concurrent use with other diabetes medications, including sulfonylureas, insulin, and repaglinide, carries a potential risk of low blood sugar that patients should be aware of.

KidneyKidneyCAUTION

Exercise caution when prescribing Voliphage-M 0.3 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Voliphage-M 0.3 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Voliphage-M 0.3 Tablet SR in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Voliphage-M 0.3 Tablet SR :

Should you forget a dose of Voliphage-M 0.3 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voliphage-M 0.3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Voliphage-M 0.3 Tablet SR
117
MRP 136
13% off